Regulation of embryonic stem cell self-renewal and differentiation by TGF-β family signaling

Science China Life Sciences

Volumn 53, Issue 4, 2010, Pages 497-503

  Fei, Teng ^a   Chen, Ye Guang ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Activin; BMP; Differentiation; Embryonic stem cell; Nodal; Self renewal; TGF

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; EMBRYONIC STEM CELL; HUMAN; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION;

ACTIVINS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

IPS;

EID: 77952317356     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-0096-2     Document Type: Review

References (59)

1. Evans M J, Kaufman M H. Establishment in culture of pluripotential cells from mouse embryos. Nature, 1981, 292: 154-156.
2. Martin G R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA, 1981, 78: 7634-7638.
3. Thomson J A, Itskovitz-Eldor J, Shapiro S S, et al. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282: 1145-1147.
4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126: 663-676.
5. Chen L, Liu L. Current progress and prospects of induced pluripotent stem cells. Sci China C Life Sci, 2009, 52: 622-636.
6. Boyer L A, Mathur D, Jaenisch R. Molecular control of pluripotency. Curr Opin Genet Dev, 2006, 16: 455-462.
7. Niwa H. How is pluripotency determined and maintained? Development, 2007, 134: 635-646.
8. Boiani M, Scholer H R. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol, 2005, 6: 872-884.
9. Datto M, Wang X F. The Smads: Transcriptional regulation and mouse models. Cytokine Growth Factor Rev, 2000, 11: 37-48.
10. Feng X H, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol, 2005, 21: 659-693.
11. Massague J, Chen Y G. Controlling TGF-beta signaling. Genes Dev, 2000, 14: 627-644.
12. Smith A G. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol, 2001, 17: 435-462.
13. Niwa H, Burdon T, Chambers I, et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev, 1998, 12: 2048-2060.
14. Ying Q L, Nichols J, Chambers I, et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell, 2003, 115: 281-292.
15. Qi X, Li T G, Hao J, et al. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA, 2004, 101: 6027-6032.
16. Fei T, Xia K, Li Z, et al. Genome-wide mapping of SMAD target genes reveals the role of BMP signaling in embryonic stem cell fate determination. Genome Res, 2010, 20: 36-44.
17. Xiao L, Yuan X, Sharkis S J. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells, 2006, 24: 1476-1486.
18. James D, Levine A J, Besser D, et al. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development, 2005, 132: 1273-1282.
19. Wu Z, Zhang W, Chen G, et al. Combinatorial signals of activin/nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells. J Biol Chem, 2008, 283: 24991-25002.
20. Xu R H, Sampsell-Barron T L, Gu F, et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell, 2008, 3: 196-206.
21. Watabe T, Miyazono K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res, 2009, 19: 103-115.
22. Liu A, Niswander L A. Bone morphogenetic protein signalling and vertebrate nervous system development. Nat Rev Neurosci, 2005, 6: 945-954.
23. Finley M F, Devata S, Huettner J E. BMP-4 inhibits neural differentiation of murine embryonic stem cells. J Neurobiol, 1999, 40: 271-287.
24. Ying Q L, Stavridis M, Griffiths D, et al. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol, 2003, 21: 183-186.
25. Vallier L, Reynolds D, Pedersen R A. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol, 2004, 275: 403-421.
26. Chambers S M, Fasano C A, Papapetrou E P, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 2009, 27: 275-280.
27. Aberdam D. Derivation of keratinocyte progenitor cells and skin formation from embryonic stem cells. Int J Dev Biol, 2004, 48: 203-206.
28. Aberdam D, Gambaro K, Rostagno P, et al. Key role of p63 in BMP-4-induced epidermal commitment of embryonic stem cells. Cell Cycle, 2007, 6: 291-294.
29. Loebel D A, Watson C M, De Young R A, et al. Lineage choice and differentiation in mouse embryos and embryonic stem cells. Dev Biol, 2003, 264: 1-14.
30. Olsen A L, Stachura D L, Weiss M J. Designer blood: Creating hematopoietic lineages from embryonic stem cells. Blood, 2006, 107: 1265-1275.
31. Nakayama N, Lee J, Chiu L. Vascular endothelial growth factor synergistically enhances bone morphogenetic protein-4-dependent lymphohematopoietic cell generation from embryonic stem cells in vitro. Blood, 2000, 95: 2275-2283.
32. Park C, Afrikanova I, Chung Y S, et al. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development, 2004, 131: 2749-2762.
33. Lee D, Park C, Lee H, et al. ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell, 2008, 2: 497-507.
34. Lengerke C, Schmitt S, Bowman T V, et al. BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell, 2008, 2: 72-82.
35. Singh A M, Terada N. Bypassing heterogeneity: The road to embryonic stem cell-derived cardiomyocyte specification. Trends Cardiovasc Med, 2007, 17: 96-101.
36. Parisi S, D'Andrea D, Lago C T, et al. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J Cell Biol, 2003, 163: 303-314.
37. Hao J, Daleo M A, Murphy C K, et al. Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One, 2008, 3: e2904.
38. Yuasa S, Itabashi Y, Koshimizu U, et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol, 2005, 23: 607-611.
39. Takei S, Ichikawa H, Johkura K, et al. Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development. Am J Physiol Heart Circ Physiol, 2009, 296: H1793-1803.
40. Buckingham M. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev, 2006, 16: 525-532.
41. He L, Vichev K, Macharia R, et al. Activin A inhibits formation of skeletal muscle during chick development. Anat Embryol (Berl), 2005, 209: 401-407.
42. Pisconti A, Brunelli S, Di Padova M, et al. Follistatin induction by nitric oxide through cyclic GMP: A tightly regulated signaling pathway that controls myoblast fusion. J Cell Biol, 2006, 172: 233-244.
43. Sakurai H, Inami Y, Tamamura Y, et al. Bidirectional induction toward paraxial mesodermal derivatives from mouse ES cells in chemically defined medium. Stem Cell Res, 2009, 3: 157-169.
44. Schulz T J, Tseng Y H. Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine Growth Factor Rev, 2009, 20: 523-531.
45. Taha M F, Valojerdi M R, Mowla S J. Effect of bone morphogenetic protein-4 (BMP-4) on adipocyte differentiation from mouse embryonic stem cells. Anat Histol Embryol, 2006, 35: 271-278.
46. Heng B C, Cao T, Lee E H. Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells, 2004, 22: 1152-1167.
47. Heng B C, Cao T, Stanton L W, et al. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res, 2004, 19: 1379-1394.
48. Kramer J, Hegert C, Guan K, et al. Embryonic stem cell-derived chondrogenic differentiation in vitro: Activation by BMP-2 and BMP-4. Mech Dev, 2000, 92: 193-205.
49. Hajare M, Delphine C, Youssef H, et al. Osteogenic differentiation of ES cell-derived EBs mediated by embedded BMP-2 and TGF-beta-1 in a polyelectrolyte multilayer film. In: M. Firestone J S, N. Malmstadt eds. Mater Res Soc Symp Proc 950E. Warrendale, PA, 2007: 0950-D0910-0904.
50. Zaret K S, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science, 2008, 322: 1490-1494.
51. Zhang D, Jiang W, Shi Y, et al. Generation of pancreatic islet cells from human embryonic stem cells. Sci China C-Life Sci, 2009, 52: 615-621.
52. Zhang D, Jiang W, Liu M, et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res, 2009, 19: 429-438.
53. Gouon-Evans V, Boussemart L, Gadue P, et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol, 2006, 24: 1402-1411.
54. Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo J D, et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol, 2006, 24: 1412-1419.
55. Erlebacher A, Price K A, Glimcher L H. Maintenance of mouse trophoblast stem cell proliferation by TGF-beta/activin. Dev Biol, 2004, 275: 158-169.
56. Schulz L C, Ezashi T, Das P, et al. Human embryonic stem cells as models for trophoblast differentiation. Placenta, 2008, 29 Suppl A: S10-16.
57. Ichida J K, Blanchard J, Lam K, et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell, 2009, 5: 491-503.
58. Lin T, Ambasudhan R, Yuan X, et al. A chemical platform for improved induction of human iPSCs. Nat Methods, 2009, 6: 805-808.
59. Maherali N, Hochedlinger K. Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol, 2009, 19: 1718-1723.